Lipocine inc

Major-Pharmaceuticals

LPCN


675 Arapeen Drive
Salt Lake City , UT 84108

Executive/
Director

Price

  • Last Close
  • $ 0.29
    $ +0.02 6.34 %
    May 11, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 2,355,880
  • Market Cap Full
  • $ 1.5M
  • Shares Outstanding
  • 5.3M
    Nov 6, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -21.5% 6% -55.5% 77.7% -5% 16.2% 38.2% -17.2% - -
Q2 -70.1% 3.1% -13.9% -13.4% 4% -7.3% -41.5% -10.4% - -
Q3 46.7% -1.2% 3.8% 47.7% 8% -22.1% -43.8% - - -
Q4 -17.5% -15.3% -5.1% -86.8% -7.8% -9.1% -14.7% - - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    146%-72%-7%-62%-71%242%-24%-61%-26%0%0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.38 0.26 -0.13 -0.14 -0.14 -0.04 -0.04 -0.68
Q2 0.32 0.31 -0.15 -0.14 -0.13 -0.08 -0.04 -0.68
Q3 0.16 0.22 -0.12 -0.12 -0.07 -0.03 -0.03 -1.27
Q4 0.16 0.25 -0.15 -0.1 -0.04 0.15 -0.34 -
A 1 1 -0.6 -0.5 -0.4 -0 -0.1 -2.63

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 23.9 47.9 88.3 88.3 88.5
Jun 21.3 21.6 47.9 88.3 88.5 88.5
Sep 21.3 24.8 65.6 88.3 88.5 5.3
Dec 21.5 25.4 65.7 88.3 88.5 5.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Interest Coverage 12 0.8 -6 - -11
Debt Ratio - - 0.1 0.2 0.3
Debt – Equity Ratio - - 0.2 0.6 0.7
Equity multiplier - - - - -